Leukosite (LKST)promising new biotech Cy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Leukosite (LKST)promising new biotech Cy?

LKST 4.260

0.0%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ACC who wrote (26)	3/31/1999 1:02:00 PM
From: Pseudo Biologist	Read Replies (1) of 35

ACC, here is some information from the Leukemia Society of America site ( leukemia.org ) * CLL: The most common types of leukemia in adults are acute myelogenous leukemia (AML) with an estimated 9,400 new cases annually; and chronic lymphocytic leukemia (CLL), with some 7,300 new cases this year. NHL: About 62,500 Americans will be diagnosed with lymphoma in 1998 (7,100 cases of Hodgkin's disease and 55,400 cases of non-Hodgkin's lymphoma.) * So, NHL seems to be a much bigger indication, and now I found out that the antibody has been tested for this indication: ncbi.nlm.nih.gov On the surface, these results do not look as good as those obtained with the IDEC or Coulter antibodies.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next